Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of weight gain when starting insulin therapy in adults with type 2 diabetes
NL-OMON20833Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Jun 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label trial of liraglutide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Erasmus MC. Primary endpoints: Weight change at 6 months and Weight change at 12 months. Planned start Jun 2011; status: not yet recruiting.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON20833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20833.